We have synthesized a series of quinolone and fluoroquinolones derivatives substituted with p-tosyl group. All these compounds were screened as antibacterial and datas were compared with reference marketed drug viz.; Ciprofloxacin & Norfloxacin.
INTRODUCTION
The antibiotic drugs such as Penicillin and cephalosporin used to treat bacterial infections by inhibit cell wall biosynthesis 1 , thereby causing bacterial cell death. In recent study quinolones are one of the largest classes of antibacterial agents used worldwide in the emergency room. They are chemotherapeutic gyrase or topoisomerases-II inhibitors eradicating bacteria by interfering with DNA replication 2 . Sulfonamide are also use as antibacterial agents. They inhibit cell metabolism of bacteria i.e. act as anti metabolites and check the growth of bacteria. Sulfonamide act as inhibitors as it mimick p-amino benzoic acid (PABA), one of the normal constitutes of folic acid. The enzyme is fooled by accepting sulfonamide into its active site as the structure of sulfonamide is similar to PABA. Once it is bound, the sulfonamide prevents PABA
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Chemistry
Here series of hydrazine and p-tosyl substituted compounds 6a-6f were synthesized and screened against bacterial infections. Substituted aniline 1 condensed with diethyl ethoxy methylene malonate 2 to give ethyl anilinomethylenemalonate 3 3 derivatives. Cyclization of the latter in diphenylether gave the substituted-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester 4.
4,5 The 1,4-dihydro-4-oxo-quinoline-3-carbohydrazide derivatives 5 is obtained by the refluxing ester 4 with hydrazine monohydrate in absolute ethanol.
The carbohydrazide derivatives 5 were treated with p-toluenesulfonyl chloride in the presence of pyridine as base and CH 2 Cl 2 , ethyl acetate as solvent. All these reaction steps involved are represented in scheme 1.
Scheme 1.

RESULTS AND DISCUSSION
Biological results of newly synthesized compounds 6a-6f by the above described method are as follows. The results of antibacterial activity of compounds 6a-6f against E.coli (ETEC) and Salmonella typhi are given in the table 2.
Minimum inhibitory concentrations of the compound 6a and 6b were not found. The compound 6c, 6d, 6e and 6f have considerable MIC. All these compounds 6a-6f was less potent to reference marketed Norfloxacin and Ciprofloxacin against bacteria E.coli and Salmonella typhi. Efforts are in progress to get more better results in this pipe line. H NMR, (300MHz) and 13 C NMR, (75MHz) spectra have been recorded on Bruker Avance 400. Melting points were determined in open capillary method and are uncorrected. All reagents were commercial grade and were used as received without further purification unless otherwise specified. Dry DMF and anhydrous potassium carbonate was used wherever required. Reagent grade solvents were used in all other cases unless otherwise specified. Organic solutions were dried over anhydrous Na 2 SO 4 and concentrated with a Buchi rotary evaporator at low pressure. Yield of purified products were not optimized.
General methods for the synthesis of substituted-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester 4 Substituted aniline 1 (0.01 mol) and diethyl ethoxy methylene malonate 2 (0.01 mol) were mixed and heated at 125-130 0 C for 2 h. Ethanol was evaporated off from the resulting mixture of ethyl anilinomethylene malonate 3. The crude solid was filtered on sintered funnel, dried and recrystallized from n-hexane. The malonate 3 (0.01 mol) was refluxed with diphenylether (50 mL) for 1 h to give 1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester 4. After 1 h the solution was cooled and the resulting precipitate was filtered off, washed with n-hexane, and dried. The solid was recrystallized from DMF to give substituted-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester 4.
Preparation of substituted-1, 4-dihydro-4-oxoquinoline-3-carbohydrazide derivatives 5
Substituted-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester 4 (0.01 mol) was refluxed for 12 h with hydrazine monohydrate (0.01 mol) in absolute ethanol ( 9 mL) to give substituted-4-oxo-1,4-dihydroquinoline-3-carbohydrazide 5. The excess solvent was evaporated off and the resulting mixture was poured into crushed ice. The solid separated was filter on sintered funnel, washed with water and dried. The crude solid was purified by recrystallized from Dioxane: ethanol to give 5 as white solid. Purity of the compound was checked on silica gel TLC plates. TLC was run in chloroform-methanol (9:1) as eluent.
Preparation of substituted-4-oxo-1,4-dihydro-3-[1-oxo-2-hydrazino-3-{p-toluenesulfon}]quinoline derivatives 6
A mixture of substituted-1, 4-dihydro-4-oxoquinoline-3-carbohydrazide derivatives 5 (0.05 mol), pyridine (0.01 mol), dichloromethane (6 mL) 
